Laplace Interventional Inc. is a medical device company in Plymouth, MN, USA. Laplace Interventional’s investigational device could potentially offer an increase in life expectancy and/or an improvement to quality of life to several patients worldwide diagnosed with Tricuspid Regurgitation (TR). Laplace Interventional is developing a Transcatheter tricuspid valve replacement (TTVR) system that delivers a prosthetic valve percutaneously not requiring an open-heart surgery and thereby reducing future complications in patients.
For general, media and investor enquires, email us at: info@laplaceint.com
Caution: Laplace Interventional's TTVR system is for investigational use only and is NOT currently available for sale in US or any other geography.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.